Skip to main content

Table 5 Mean baseline outcomes by trial arm

From: Lee Silverman Voice Treatment versus standard speech and language therapy versus control in Parkinson’s disease: preliminary cost-consequence analysis of the PD COMM pilot randomised controlled trial

Outcome

Mean (95% CI)

LSVT® LOUD

(n = 29)

NHS SLT

(n = 30)

Control

(n = 29)

VHI

41.7 (34.3, 49.4)

42.2 (33.3, 51.9)

42.4 (34.8, 50.9)

PDQ39-COMM

35.3 (27.3, 44.1)

32.8 (25.8, 40.8)

33.3 (27.0, 41.4)

PDQ-39 summary

32.4 (26.8, 37.8)

28.1 (23.6, 33.2)

26.4 (21.7, 31.6)

EQ-5D-3L

0.59 (0.48, 0.69)

0.64 (0.56, 0.72)

0.72 (0.66, 0.78)

ICECAP-O

0.79 (0.74, 0.84)

0.78 (0.70, 0.83)

0.75 (0.66, 0.82)